	US 11,738,057 B2
	Lactobacillus having blood glucose lowering effect and antioxidant effect
Nam-Soo Paek, Seoul (KR); and Chang Ho Kang, Chungcheongbuk-do (KR)
Assigned to Mediogen Co., Ltd., Chungcheongbuk-do (KR)
Filed by MEDIOGEN CO., LTD., Chungcheongbuk-do (KR); and Nam-Soo Paek, Seoul (KR)
Filed on Jul. 22, 2020, as Appl. No. 16/936,211.
Claims priority of application No. 10-2019-0088795 (KR), filed on Jul. 23, 2019.
Prior Publication US 2021/0023147 A1, Jan. 28, 2021
Int. Cl. A61K 39/02 (2006.01); A01N 63/00 (2020.01); A61K 35/747 (2015.01); A61P 3/10 (2006.01); A61K 35/00 (2006.01)

CPC A61K 35/747 (2013.01) [A61P 3/10 (2018.01); A61K 2035/115 (2013.01)]

13 Claims

1. A method for lowering a blood glucose level in a subject, the method comprising:

administering to the subject a composition comprising an effective dose of a Lactobacillus plantarum MG4229 strain (Accession No. KCTC13854BP) having blood glucose lowering activity and antioxidant activity, a conditioned culture medium by culturing of the strain, or a cell-free supernatant of the strain.